IPO, Ceribell
Ceribell’s stock indicates up 35% in trading debut after pricing IPO at top of range
Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a strong trading debut Friday, after its initial public offering priced at the top of its proposed range.
CeriBell, EEG developer, sees stock rally 35% following $180M IPO
CeriBell (NASDAQ:CBLL) shares rallied 35% Friday following the medical device maker’s $180M initial public offering. Shares of CeriBell (CBLL) opened at $23.26 after being priced at $17 per share, later reaching a high of $23.
Ceribell begins trading with upsized IPO
Ceribell Inc. launched its initial public offering of more than 10.6 million shares of common stock at $17 and steadily saw the trading value rise, before closing just over $25 on Oct. 11 per share. Ceribell,
CeriBell Shares Set for Trading Debut After Pricing IPO at High End of Views
CeriBell shares are slated to make their trading debut Friday after the company's upsized initial public offering was priced at the high end of expectations. The Sunnyvale, Calif., medical technology company late Thursday said it is selling 10.6 million shares at $17 each in the IPO.
Neurotech company CeriBell prices $180.3M IPO
CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 million.
TPG-backed CeriBell seeks up to $578 mln valuation in upsized US IPO
TPG-backed CeriBell is targeting as much as $578.3 million valuation in its upsized initial public offering in the United States, the medical device maker said on Wednesday, indicating robust investor optimism for healthcare startups.
Upstream Bio stock rallies 32% following upsized $255M IPO
Upstream Bio (UPB) shares rallied 32% Friday following the asthma drug developer’s $255M upsized initial public offering. Read more here.
Ceribell Up 49% in Debut After Upsized IPO
Ceribell shares were higher in their Nasdaq debut after an upsized initial public offering priced at the high end of a projected range. Shares of Ceribell, maker of an AI-powered brain monitoring system that detects seizure activity,
CeriBell Goes Public in Rare Medical-Device IPO
The company’s upsized offering is a hopeful sign for venture investors in the sector.
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs
Three US life-sciences companies hitting the market delivered mostly robust early trading after investors strongly supported ...
Upstream Bio, two other U.S. biotech startups price IPOs as healthcare listings rise
Three U.S. healthcare startups priced their initial public offerings (IPO) on Thursday, including Upstream Bio which raised ...
Preview: Ceribell, Inc Set To IPO Tomorrow
CeriBell, Inc CBLL IPO will take place October, 11 on the NASDAQ exchange under the ticker CBLL. The company is offering ...
FierceBiotech4d
Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO
Ceribell, the maker of a portable, brain-reading headset for emergency seizure care, aims to go public on the Nasdaq through ...